These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21397212)

  • 41. [Reading comprehension of students with attention deficit hyperactivity disorder: what is the role of executive functions?].
    Miranda-Casas A; Fernández MI; Robledo P; García-Castellar R
    Rev Neurol; 2010 Mar; 50 Suppl 3():S135-42. PubMed ID: 20200841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synaptogenesis and heritable aspects of executive attention.
    Fossella JA; Sommer T; Fan J; Pfaff D; Posner MI
    Ment Retard Dev Disabil Res Rev; 2003; 9(3):178-83. PubMed ID: 12953297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
    Roberts GM; Garavan H
    Neuroimage; 2010 Aug; 52(2):429-35. PubMed ID: 20417713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An approach to the executive functions in autism spectrum disorder].
    Martos-Pérez J; Paula-Pérez I
    Rev Neurol; 2011 Mar; 52 Suppl 1():S147-53. PubMed ID: 21365597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation.
    Kehagia AA; Murray GK; Robbins TW
    Curr Opin Neurobiol; 2010 Apr; 20(2):199-204. PubMed ID: 20167474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Executive functions and self-regulation.
    Hofmann W; Schmeichel BJ; Baddeley AD
    Trends Cogn Sci; 2012 Mar; 16(3):174-80. PubMed ID: 22336729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Executive (dys)function after stroke: special considerations for behavioral pharmacology.
    Povroznik JM; Ozga JE; Vonder Haar C; Engler-Chiurazzi EB
    Behav Pharmacol; 2018 Oct; 29(7):638-653. PubMed ID: 30215622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. I can't get no satisfaction: potential causes of boredom.
    Gerritsen CJ; Toplak ME; Sciaraffa J; Eastwood J
    Conscious Cogn; 2014 Jul; 27():27-41. PubMed ID: 24794051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a proactive and a reactive mechanism of inhibition? Towards an executive account of the attentional inhibitory control model.
    Perri RL
    Behav Brain Res; 2020 Jan; 377():112243. PubMed ID: 31539574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What do we know about the relationship between source monitoring deficits and executive dysfunction?
    El Haj M; Allain P
    Neuropsychol Rehabil; 2012; 22(3):449-72. PubMed ID: 22324387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenetics of monoamine transporters.
    Glatt CE; Reus VI
    Pharmacogenomics; 2003 Sep; 4(5):583-96. PubMed ID: 12943466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An adaptive orienting theory of error processing.
    Wessel JR
    Psychophysiology; 2018 Mar; 55(3):. PubMed ID: 29226960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the molecular genetics of the development of executive attention in children: focus on genetic pathways related to the anterior cingulate cortex and dopamine.
    Brocki K; Clerkin SM; Guise KG; Fan J; Fossella JA
    Neuroscience; 2009 Nov; 164(1):241-6. PubMed ID: 19344637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conditional automaticity in response selection: contingent involuntary response inhibition with varied stimulus-response mapping.
    Anderson BA; Folk CL
    Psychol Sci; 2014 Feb; 25(2):547-54. PubMed ID: 24357615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition.
    Logue SF; Gould TJ
    Pharmacol Biochem Behav; 2014 Aug; 123():45-54. PubMed ID: 23978501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The inhibitory control reflex.
    Verbruggen F; Best M; Bowditch WA; Stevens T; McLaren IP
    Neuropsychologia; 2014 Dec; 65():263-78. PubMed ID: 25149820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Serotonin (5-HT) in Behavioral Control: Findings from Animal Research and Clinical Implications.
    Sanchez CL; Biskup CS; Herpertz S; Gaber TJ; Kuhn CM; Hood SH; Zepf FD
    Int J Neuropsychopharmacol; 2015 May; 18(10):pyv050. PubMed ID: 25991656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation.
    Robbins TW; Arnsten AF
    Annu Rev Neurosci; 2009; 32():267-87. PubMed ID: 19555290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?
    Bowirrat A; Chen TJ; Oscar-Berman M; Madigan M; Chen AL; Bailey JA; Braverman ER; Kerner M; Giordano J; Morse S; Downs BW; Waite RL; Fornari F; Armaly Z; Blum K
    Mol Neurobiol; 2012 Apr; 45(2):298-313. PubMed ID: 22371275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.